ACUTE LYMPHOBLASTIC LEUKEMIA, REFRACTORY
Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA, REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKEMIA, REFRACTORY trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKEMIA, REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered donor cells take on childhood leukemia in first human test
Disease control Recruiting nowThis early-stage trial tests a new type of cell therapy for children and young adults up to age 21 with a form of leukemia (CD19-positive) that has returned or not responded to treatment. The therapy uses immune cells from a family donor that are engineered in a lab to recognize …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA, REFRACTORY
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Hospital-Made cancer fighters: new CAR-T trial for leukemia
Disease control Recruiting nowThis study is testing whether a personalized cell therapy called MB-CART19.1 can be manufactured right at the hospital for children and adults with B-cell acute lymphoblastic leukemia that has come back or not responded to standard treatments. The therapy uses the patient's own i…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA, REFRACTORY
Phase: NA • Sponsor: King Hussein Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Engineered immune cells take on Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-phase study tests a personalized therapy where a patient's own immune cells are modified to recognize and attack cancer cells. It is for children and adults with certain blood cancers (like leukemia or lymphoma) that have not responded to standard treatments. The goal …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA, REFRACTORY
Phase: PHASE1 • Sponsor: Nelson Hamerschlak • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC